134 related articles for article (PubMed ID: 11050305)
1. L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey.
Forrest MJ; Hom G; Bach T; Candelore MR; Cascieri MA; Strader C; Tota L; Fisher MH; Szumiloski J; Ok HO; Weber AE; Wyvratt M; Vicario P; Marko O; Deng L; Cioffe C; Hegarty-Friscino B; MacIntyre E
Eur J Pharmacol; 2000 Oct; 407(1-2):175-81. PubMed ID: 11050305
[TBL] [Abstract][Full Text] [Related]
2. Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys.
Hom GJ; Forrest MJ; Bach TJ; Brady E; Candelore MR; Cascieri MA; Fletcher DJ; Fisher MH; Iliff SA; Mathvink R; Metzger J; Pecore V; Saperstein R; Shih T; Weber AE; Wyvratt M; Zafian P; MacIntyre DE
J Pharmacol Exp Ther; 2001 Apr; 297(1):299-307. PubMed ID: 11259557
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
Whalen EJ; Bates JN; Johnson AK; Lewis SJ
Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
[TBL] [Abstract][Full Text] [Related]
4. Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides.
Brockunier LL; Parmee ER; Ok HO; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Tota L; Wyvratt MJ; Fisher MH; Weber AE
Bioorg Med Chem Lett; 2000 Sep; 10(18):2111-4. PubMed ID: 10999482
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents.
Biftu T; Feng DD; Liang GB; Kuo H; Qian X; Naylor EM; Colandrea VJ; Candelore MR; Cascieri MA; Colwell LF; Forrest MJ; Hom GJ; MacIntyre DE; Stearns RA; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
Bioorg Med Chem Lett; 2000 Jul; 10(13):1431-4. PubMed ID: 10888325
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
[TBL] [Abstract][Full Text] [Related]
7. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
[TBL] [Abstract][Full Text] [Related]
9. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.
Fisher MH; Amend AM; Bach TJ; Barker JM; Brady EJ; Candelore MR; Carroll D; Cascieri MA; Chiu SH; Deng L; Forrest MJ; Hegarty-Friscino B; Guan XM; Hom GJ; Hutchins JE; Kelly LJ; Mathvink RJ; Metzger JM; Miller RR; Ok HO; Parmee ER; Saperstein R; Strader CD; Stearns RA; MacIntyre DE
J Clin Invest; 1998 Jun; 101(11):2387-93. PubMed ID: 9616210
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective human beta(3)-adrenergic receptor antagonists.
Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
[TBL] [Abstract][Full Text] [Related]
11. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of β
Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
[TBL] [Abstract][Full Text] [Related]
13. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.
Whalen EJ; Lewis SJ
Eur J Pharmacol; 1999 Oct; 382(3):207-10. PubMed ID: 10556671
[TBL] [Abstract][Full Text] [Related]
15. Beta3 adrenergic stimulation inhibits the opossum lower esophageal sphincter.
Dimarino M; Banwait K; Rattan S; Cohen S; DiMarino AJ
Gastroenterology; 2002 Nov; 123(5):1508-15. PubMed ID: 12404226
[TBL] [Abstract][Full Text] [Related]
16. Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.
Kozłowska H; Szymska U; Schlicker E; Malinowska B
Br J Pharmacol; 2003 Sep; 140(1):3-12. PubMed ID: 12967929
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
18. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
19. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105
[TBL] [Abstract][Full Text] [Related]
20. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
Grove A; McFarlane LC; Lipworth BJ
Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
